Search Results - "Fluttaz, C."

Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort by Fond, G., Godin, O., Boyer, L., Berna, F., Andrianarisoa, M., Coulon, N., Brunel, L., Bulzacka, E., Aouizerate, B., Capdevielle, D., Chereau, I., D’Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Leignier, S., Lançon, C., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Schandrin, A., Urbach, M., Vidailhet, P., Llorca, P. M., Schürhoff, F., Leboyer, M.

“…A high rate of patients with schizophrenia (SZ) does not sufficiently respond to antipsychotic medication, which is associated with relapses and poor outcomes…”
Get full text

Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort by Fond, G., Boyer, L., Schürhoff, F., Berna, F., Godin, O., Bulzacka, E., Andrianarisoa, M., Brunel, L., Aouizerate, B., Capdevielle, D., Chereau, I., Coulon, N., D'Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Lançon, C., Leignier, S., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Schandrin, A., Urbach, M., Vidailhet, P., Llorca, P.M., Leboyer, M., Andrianarisoa, M., Aouizerate, B., Bazin, N., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Coulon, N., Danion, J.M., D'Amato, T., Deloge, A., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Jarroir, M., Leignier, S., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Ramet, L., Rey, R., Roman, C., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A.

“…Latent Toxoplasma infection has been associated with widespread brain immune activation, increased blood brain barrier permeability, neural disruption,…”
Get full text

Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort by Mallet, J., Le Strat, Y., Schürhoff, F., Mazer, N., Portalier, C., Andrianarisoa, M., Aouizerate, B., Berna, F., Brunel, L., Capdevielle, D., Chereau, I., D’Amato, T., Dubreucq, J., Faget, C., Gabayet, F., Honciuc, R. M., Lançon, C., Llorca, P. M., Misdrahi, D., Rey, R., Roux, P., Schandrin, A., Urbach, M., Vidailhet, P., Fond, G., Dubertret, C.

“…Tobacco smoking is common in schizophrenia and is one of the main causes of premature mortality in this disorder. Little is known about clinical correlates and…”
Get full text

Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort by Mallet, J., Le Strat, Y., Schürhoff, F., Mazer, N., Portalier, C., Andrianarisoa, M., Aouizerate, B., Berna, F., Brunel, L., Capdevielle, D., Chereau, I., D'Amato, T., Denizot, H., Dubreucq, J., Faget, C., Gabayet, F., Lançon, C., Llorca, P.M., Misdrahi, D., Rey, R., Roux, P., Schandrin, A., Urbach, M., Vidailhet, P., Fond, G., Dubertret, C., Andrianarisoa, M., Aouizerate, B., Bazin, N., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Ramet, L., Rey, R., Roman, C., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A.

“…Tobacco use is common in patients with schizophrenia (SZ) but little is known on the role of tobacco in the physiopathology or on the course of the disease…”
Get full text

Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort by Fond, G., Resseguier, N., Schürhoff, F., Godin, O., Andrianarisoa, M., Brunel, L., Bulzacka, E., Aouizerate, B., Berna, F., Capdevielle, D., Chereau, I., D’Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Lançon, C., Llorca, P. M., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Schandrin, A., Urbach, M., Vidailhet, P., Boyer, L., Leboyer, M.

“…Low-grade inflammation has repeatedly been associated with schizophrenia (SZ) and in particular with cognitive impairment. Female gender, overweight and…”
Get full text

Towards an improved access to psychiatric rehabilitation: availability and effectiveness at 1-year follow-up of psychoeducation, cognitive remediation therapy, cognitive behaviour therapy and social skills training in the FondaMental Advanced Centers of Expertise-Schizophrenia (FACE-SZ) national cohort by Dubreucq, Julien, Ycart, B., Gabayet, F., Perier, C. C., Hamon, A., Llorca, P. M., Boyer, L., Godin, O., Bulzacka, E., Andrianarisoa, M., Aouizerate, B., Berna, F., Brunel, L., Capdevielle, D., Chereau, I., D’Amato, T., Dubertret, C., Faget, C., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Richieri, R., Schandrin, A., Schürhoff, F., Urbach, M., Vidailhet, P., Giraud-Baro, E., Fond, G.

“…Psychosocial Interventions (PIs) have shown positive effects on clinical and functional outcomes of schizophrenia (SZ) in randomized controlled trials. However…”
Get full text

Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort by Foiselle, Marianne, Barbosa, Susana, Godin, Ophélia, Wu, Ching-Lien, Boukouaci, Wahid, Andre, Myrtille, Aouizerate, Bruno, Berna, Fabrice, Barau, Caroline, Capdevielle, Delphine, Vidailhet, Pierre, Chereau, Isabelle, Davidovic, Laetitia, Dorey, Jean-Michel, Dubertret, Caroline, Dubreucq, Julien, Faget, Catherine, Fond, Guillaume, Leigner, Sylvain, Llorca, Pierre-Michel, Mallet, Jasmina, Misdrahi, David, Martinuzzi, Emanuela, Passerieux, Christine, Rey, Romain, Pignon, Baptiste, Urbach, Mathieu, Schürhoff, Franck, Glaichenhaus, Nicolas, Leboyer, Marion, Tamouza, Ryad, Berna, F., Haffen, E., Leboyer, M., Llorca, P.M., Schürhoff, F., Barteau, V., Bensalem, S., Godin, O., Laouamri, H., Souryis, K., Leboyer, M., Offerlin-Meyer, I., Pignon, B., Schürhoff, F., Szöke, A., Aouizerate, B., Deloge, A., Misdrahi, D., Vilà, E., Blanc, O., Chéreau, I., Denizot, H., Honciuc, R.M., Lacelle, D., Llorca, P.M., Pires, S., Dubertret, C., Mallet, J., Portalier, C., Dubreucq, J., Fluttaz, C., Gabayet, F., Roman, C., Chesnoy-Servanin, G., D'Amato, T., Dorey, J.M., Rey, R., Vehier, A., Lançon, C., Faget, C., Metairie, E., Peri, P., Vaillant, F., Boyer, L., Fond, G., Berna, F., Vidailhet, P., Zinetti-Bertschy, A., Capdevielle, D., Yazbek, H., Esselin, S., Jarroir, M., Passerieux, C., Urbach, M.

“…Metabolic syndrome (MetS) is a highly prevalent and harmful medical disorder often comorbid with psychosis where it can contribute to cardiovascular…”
Get full text

Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort by Misdrahi, David, Tessier, Arnaud, Daubigney, Antoine, Meissner, Wassilios G, Schurhoff, Franck, Boyer, Laurent, Godin, Ophélia, Bulzacka, Ewa, Aouizerate, Bruno, Andrianarisoa, Meja, Berna, Fabrice, Capdevielle, Delphine, Chereau-Boudet, Isabelle, D'Amato, Thierry, Dubertret, Caroline, Dubreucq, Julien, Faget-Agius, Catherine, Lançon, Christophe, Mallet, Jasmina, Passerieux, Christine, Rey, Romain, Schandrin, Aurélie, Urbach, Mathieu, Vidailhet, Pierre, Llorca, Pierre-Michel, Fond, Guillaume

“…Extrapyramidal side effects (EPS) have been identified as a complication of antipsychotic treatment. Previous meta-analyses have investigated EPS prevalence…”
Get full text

Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort by Andrianarisoa, M, Boyer, L, Godin, O, Brunel, L, Bulzacka, E, Aouizerate, B, Berna, F, Capdevielle, D, Dorey, J.M, Dubertret, C, Dubreucq, J, Faget, C, Gabayet, F, Llorca, P.M, Mallet, J, Misdrahi, D, Rey, R, Richieri, R, Passerieux, C, Schandrin, A, Tronche, A.M, Urbach, M, Vidailhet, P, Schürhoff, F, Fond, G

“…Abstract Objectives Depression and negative symptoms have been associated with impaired Quality of life (QoL) in schizophrenia (SZ). However, childhood trauma…”
Get full text

A National network of schizophrenia expert centres: An innovative tool to bridge the research-practice gap by Schürhoff, F, Fond, G, Berna, F, Bulzacka, E, Vilain, J, Capdevielle, D, Misdrahi, D, Leboyer, M, Llorca, P.-M

“…Abstract Schizophrenia is probably the most severe psychiatric disorder with much suffering for the patients and huge costs for the society. Efforts to provide…”
Get full text

Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort by Godin, O, Leboyer, M, Gaman, A, Aouizerate, B, Berna, F, Brunel, L, Capdevielle, D, Chereau, I, Dorey, J.M, Dubertret, C, Dubreucq, J, Faget, C, Gabayet, F, Le Strat, Y, Llorca, P.M, Misdrahi, D, Rey, R, Richieri, R, Passerieux, C, Schandrin, A, Schürhoff, F, Urbach, M, Vidalhet, P, Girerd, N, Fond, G

“…Abstract Objective Abdominal obesity was suggested to be a better predictor than Metabolic Syndrome (MetS) for cardiovascular mortality, however this is has…”
Get full text

Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort by Fond, G., Bulzacka, E., Boucekine, M., Schürhoff, F., Berna, F., Godin, O., Aouizerate, B., Capdevielle, D., Chereau, I., D'Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Leignier, S., Lançon, C., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Schandrin, A., Urbach, M., Vidailhet, P., Leboyer, M., Boyer, L., Llorca, P.M.

“…Predicting psychotic relapse is one of the major challenges in the daily care of schizophrenia. To determine the predictors of psychotic relapse and follow-up…”
Get full text

Relationship between childhood trauma and level of insight in schizophrenia: A path-analysis in the national FACE-SZ dataset by Pignon, Baptiste, Lajnef, Mohamed, Godin, Ophélia, Geoffray, Marie-Maud, Rey, Romain, Mallet, Jasmina, Dubertret, Caroline, Roux, Paul, Passerieux, Christine, Marulaz, Laurent, Brunel, Lore, Dubreucq, Julien, Leignier, Sylvain, Capdevielle, Delphine, André, Myrtille, Aouizerate, Bruno, Misdrahi, David, Berna, Fabrice, Vidailhet, Pierre, Chereau, Isabelle, Llorca, Pierre-Michel, Fond, Guillaume, Lançon, Christophe, Leboyer, Marion, Schürhoff, Franck, Andrianarisoa, M.D., Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, Jm, D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M.C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schurhoff, F., Tessier, A., Tronche, Am, Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A.

“…This study aimed was to investigate the relationship between different types of childhood trauma and the level of insight (i.e., awareness of having a…”
Get full text

Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort by Vidal, Nathan, Roux, Paul, Urbach, Mathieu, Belmonte, Cristobal, Boyer, Laurent, Capdevielle, Delphine, Clauss-Kobayashi, Julie, D'Amato, Thierry, Dassing, Romane, Dubertret, Caroline, Dubreucq, Julien, Fond, Guillaume, Honciuc, Roxana-Mihaela, Leignier, Sylvain, Llorca, Pierre-Michel, Mallet, Jasmina, Misdrahi, David, Pignon, Baptiste, Rey, Romain, Schürhoff, Franck, Tessier, Arnaud, Passerieux, Christine, Brunet-Gouet, Eric

“…The anticholinergic properties of medications are associated with poorer cognitive performance in schizophrenia. Numerous scales have been developed to assess…”
Get full text

Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset by Berna, F, Misdrahi, D, Boyer, L, Aouizerate, B, Brunel, L, Capdevielle, D, Chereau, I, Danion, J.M, Dorey, J.M, Dubertret, C, Dubreucq, J, Faget, C, Gabayet, F, Lancon, C, Mallet, J, Rey, R, Passerieux, C, Schandrin, A, Schurhoff, F, Tronche, A.M, Urbach, M, Vidailhet, P, Llorca, P.M, Fond, G

“…AbstractThe main objective of this study was to determine the prevalence of akathisia in a community-dwelling sample of patients with schizophrenia, and to…”
Get full text

Mediation Analyses of Insight, Quality of Life, Depression, and Suicidality: Results From the FACE-SZ Cohort by Roux, Paul, Misdrahi, David, Capdevielle, Delphine, Aouizerate, Bruno, Berna, Fabrice, Brunel, Lore, Chereau, Isabelle, Dorey, Jean-Michel, Dubertret, Caroline, Dubreucq, Julien, Faget-Agius, Catherine, Fonteneau, Sandrine, Gabayet, Franck, Llorca, Pierre Michel, Mallet, Jasmina, Rey, Romain, Richieri, Raphaëlle, Schandrin, Aurélie, Schürhoff, Franck, Tessier, Arnaud, Vidailhet, Pierre, Passerieux, Christine, Urbach, Mathieu

“…The relationship between greater insight and increased risk of suicide in patients with schizophrenia is debated. The purpose of this study was to assess…”
Get full text

Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset by Fond, G., Boyer, L., Andrianarisoa, M., Godin, O., Brunel, L., Bulzacka, E., Coulon, N., Llorca, P.M., Berna, F., Aouizerate, B., Capdevielle, D., D'Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Mallet, J., Misdrahi, D., Rey, R., Richieri, R., Roux, P., Passerieux, C., Schandrin, A., Tronche, A.M., Vidailhet, P., Leboyer, M., Schürhoff, F., Andrianarisoa, M., Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M.C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schurhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A.

“…Reducing the duration of untreated psychosis (DUP) may improve the prognosis of schizophrenia. This study investigated the prevalence, and associated risk…”
Get full text

A multi-dimensional approach to the relationship between insight and aggressiveness in schizophrenia: Findings from the FACE-SZ cohort by Schandrin, A., Norton, J., Raffard, S., Aouizerate, B., Berna, F., Brunel, L., Chereau-Boudet, I., D'Amato, T., Denizot, H., Dubertret, C., Dubreucq, J., Faget, C., Fond, G., Gabayet, F., Llorca, P.M., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Schurhoff, F., Urbach, M., Bonnet, S., Capdevielle, D., Andrianarisoa, M., Aouizerate, B., Bazin, N., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Ramet, L., Rey, L., Roman, C., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A.

“…Aggressiveness is a stigma frequently associated with schizophrenia. The role of insight as a risk factor of aggressiveness remains contradictory; mainly…”
Get full text

Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set by Fond, G, Godin, O, Brunel, L, Aouizerate, B, Berna, F, Bulzacka, E, Capdevielle, D, Chereau, I, Dorey, J.M, Dubertret, C, Dubreucq, J, Faget, C, Gabayet, F, Le Strat, Y, Micoulaud-Franchi, J.A, Misdrahi, D, Rey, R, Richieri, R, Passerieux, C, Schandrin, A, Schürhoff, F, Tronche, A.M, Urbach, M, Vidalhet, P, Llorca, P.M, Leboyer, M

“…Abstract Objectives The relation between C-Reactive Protein (CRP), depression and antidepressant consumption has been well explored in major depressive…”
Get full text

Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort by Fond, G., Godin, O., Schürhoff, F., Berna, F., Aouizerate, B., Capdevielle, D., Chereau, I., D'Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Leignier, S., Lançon, C., Mallet, J., Marulaz, L., Misdrahi, D., Passerieux, C., Rey, R., Schandrin, A., Urbach, M., Vidailhet, P., Leboyer, M., Boyer, L., Llorca, P.M.

“…•Major depression is a therapeutic challenge in schizophrenia.•Untangling different forms of major depression appears as the best current strategy to improve…”
Get full text